Trial analysis reveals almost all adults with hypertensive chronic kidney disease would benefit from intensive blood pressure lowering
Reports and Proceedings
Updates every hour. Last Updated: 15-Jan-2026 03:11 ET (15-Jan-2026 08:11 GMT/UTC)
Nearly all SPRINT participants with hypertension and nondiabetic chronickidney disease stages 3–4 had a net benefit (the predicted difference between benefits and harms) that favored a systolic blood pressure target of <120 mm Hg compared with <140 mm Hg.
The findings will be presented at American Society of Nephrology (ASNKidney Week 2025 November 5–9.
A mismatch between two common tests for kidney function may indicate a higher risk for kidney failure, heart disease, and death, a new study shows.
In a new study, coauthors Jordan Yaron, Kaushal Rege and their colleagues with the Biodesign Center for Biomaterials Innovation and Translation discovered that the protein SerpinB3 is part of the body’s natural wound-healing arsenal, helping the skin recover after damage.
The research points to new possibilities: Boosting it could improve wound healing, while blocking it may offer a way to fight aggressive cancers. The findings may also help explain SerpinB3’s role in inflammatory ailments, from skin conditions to asthma.
New studies from Arizona State University reveal surprising ways bacteria can move without their flagella — the slender, whip-like propellers that usually drive them forward.
Movement lets bacteria form communities, spread to new places or escape from danger. Understanding how they do it can help us develop new tools to fight against infections.